drugset / Trial / NCT00233558
Open-Label Steroid Reduction Study of Adalimumab With Methotrexate in Patients With Active Rheumatoid Arthritis
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of the study is to evaluate the clinical efficacy of scheduled versus free reduction of steroid treatment in patients with active RA treated with adalimumab + MTX
Timeline
- Start
- 2005-06
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Adalimumab | Monoclonal antibody | 40 mg | — |
| Background | Methotrexate | Small molecule | — | — |